Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Alzheimer's Disease

  Free Subscription


11.05.2020

1 Alzheimer Dis Assoc Disord
1 Alzheimers Dement
3 Am J Geriatr Psychiatry
1 Brain
1 J Neurochem
1 Neurobiol Aging
1 Neurology
1 Neurosci Lett
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. KITAMURA J, Nagai M, Ueno H, Ohshita T, et al
    The Insular Cortex, Alzheimer Disease Pathology, and Their Effects on Blood Pressure Variability.
    Alzheimer Dis Assoc Disord. 2020 May 6. doi: 10.1097/WAD.0000000000000340.
    PubMed         Abstract available


    Alzheimers Dement

  2. MOORE EE, Gifford KA, Khan OA, Liu D, et al
    Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease.
    Alzheimers Dement. 2020 May 6. doi: 10.1002/alz.12087.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  3. BEAUDREAU SA, Schneider L
    Commentary on "The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum".
    Am J Geriatr Psychiatry. 2020 Apr 15. pii: S1064-7481(20)30291.
    PubMed        

  4. ALMEIDA OP, Ford AH
    Are We Getting Better at Managing Agitation in Dementia?
    Am J Geriatr Psychiatry. 2020;28:401-403.
    PubMed        

  5. ISAIA G, Marinello R, Tibaldi V, Tamone C, et al
    Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease.
    Am J Geriatr Psychiatry. 2020 Apr 22. pii: S1064-7481(20)30319.
    PubMed        


    Brain

  6. MALPETTI M, Kievit RA, Passamonti L, Jones PS, et al
    Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Brain. 2020 May 7. pii: 5831943. doi: 10.1093.
    PubMed         Abstract available


    J Neurochem

  7. MUNTER LM
    The lipid component of Alzheimer's disease research: An Editorial Highlight for "Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice" on https://do
    J Neurochem. 2020 May 6. doi: 10.1111/jnc.15025.
    PubMed         Abstract available


    Neurobiol Aging

  8. LIM B, Sando SB, Grontvedt GR, Brathen G, et al
    Cerebrospinal fluid neuronal pentraxin receptor as a biomarker of long-term progression of Alzheimer's disease: a 24-month follow-up study.
    Neurobiol Aging. 2020 Mar 31. pii: S0197-4580(20)30098.
    PubMed         Abstract available


    Neurology

  9. BERNATH MM, Bhattacharyya S, Nho K, Barupal DK, et al
    Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers.
    Neurology. 2020 May 1. pii: WNL.0000000000009436.
    PubMed         Abstract available


    Neurosci Lett

  10. KONG Y, Peng Q, Lv N, Yuan J, et al
    Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer's disease via activation of adenosine A1 receptor.
    Neurosci Lett. 2020 May 1:135016. doi: 10.1016/j.neulet.2020.135016.
    PubMed         Abstract available


    PLoS One

  11. ICHINOSE T, Murasawa H, Ishijima T, Okada S, et al
    Tyr-Trp administration facilitates brain norepinephrine metabolism and ameliorates a short-term memory deficit in a mouse model of Alzheimer's disease.
    PLoS One. 2020;15:e0232233.
    PubMed         Abstract available

  12. LARGENT EA, Harkins K, van Dyck CH, Hachey S, et al
    Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.
    PLoS One. 2020;15:e0229137.
    PubMed         Abstract available

  13. HIN N, Newman M, Kaslin J, Douek AM, et al
    Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2.
    PLoS One. 2020;15:e0227258.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: